Bridgeway Ultra- Small Company Market Fund
BRSIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 55615 Kirby Drive, Suite 518Houston,TX 77005United States TX United States of America
- IPO Date
- Jul 31, 1997
- CIK
- 0000916006
- Website
- bridgeway.com
- Similar Companies
- Business
- Bridgeway Ultra-Small Company Market Fund (BRSIX) is an open-end mutual fund that seeks long-term total return on capital, primarily through capital appreciation, by investing at least 80% of its net assets in ultra-small company stocks approximating the CRSP Cap-Based Portfolio 10 Index. The fund defines ultra-small companies as those with market capitalizations in the smallest 10% of New York Stock Exchange-listed firms or within the CRSP 10 Index range, holding a diversified portfolio of approximately 535 stocks with a weighted average market cap of $266 million, low price-to-sales ratio of 0.6, and sector allocations led by health care (25.8%), financials (18.4%), and consumer discretionary (13.0%). Top holdings include Kodiak Sciences Inc. (0.87%), XOMA Royalty Corp. (0.76%), and Prime Medicine Inc. (0.69%), with a net expense ratio of 0.75%, no front-end or deferred loads, and a 2% maximum redemption fee; the fund is managed by a team including John Montgomery (since inception), Elena Khoziaeva, CFA (since 2005), Christine Wang, CFA, CPA (since 2010), and Andrew L. Berkin, PhD (since 2024). Part of the Bridgeway Funds family advised by Bridgeway Capital Management, LLC, a Houston, Texas-based investment adviser founded in 1993 that manages nine no-load mutual funds using statistically driven, evidence-based equity strategies focused on small-cap value and factor investing for institutions, financial advisors, high-net-worth individuals, and non-profits. The firm, which employs about 27 staff and donates at least 50% of profits to non-profits, offers related funds such as Omni Small-Cap Value (BOSVX), Small-Cap Value (BRSVX), and the recently launched Global Opportunities Fund (BRGOX, inception October 2024) employing long/short techniques for market-neutral returns; BRSIX, launched July 31, 1997, has net assets of $121 million and operates exclusively in U.S. equities (99.19% allocation). Recent developments include strong performance with a one-year total return of 23.30% as of September 30, 2025 (outpacing the Russell Microcap Index's 22.56%), YTD return of 11.38%, and five-year annualized return of 12.87%, alongside portfolio updates reflected in the January 2025 fact sheet showing net assets grown to $180 million, turnover of 44%, and new top holdings like Natural Gas Service Group Inc. (0.9%) and Dwave Quantum Inc. (0.8%). Bridgeway Capital Management continues to expand its evidence-based offerings, with the addition of Andrew L. Berkin to the BRSIX team in mid-2024 and ongoing 13F filings as of June 30, 2025, disclosing $4 billion in equity positions and increased stakes in leading technology firms such as NVIDIA and Microsoft. No major acquisitions, funding rounds, or strategic alliances specific to BRSIX or Bridgeway Funds were reported in the last 1-2 years.